Farther Finance Advisors’s Arcus Biosciences RCUS Stock Holding History

Farther Finance Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.26K	Sell	138 -25	-15%	-$618	﹤0.01%	4882
2026 Q1	$3.56K	Sell	163 -17	-9%	-$367	﹤0.01%	4666
2025 Q4	$4.29K	Buy	180 +9	+5%	+$184	﹤0.01%	4391
2025 Q3	$2.33K	Buy	+171	New	+$1.78K	﹤0.01%	4081
2025 Q1	–	Sell	-1	Closed	-$15	–	4393
2024 Q4	$15	Hold	1	–	–	﹤0.01%	3952
2024 Q3	$15	Buy	+1	New	+$16	﹤0.01%	3936
2024 Q1	–	Sell	-1	Closed	-$19	–	3713
2023 Q4	$19	Buy	+1	New	+$16	﹤0.01%	3466

Other funds holding RCUS

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Farther Finance Advisors's RCUS Position: Q2 2026 in Review

Farther Finance Advisors reduced its Arcus Biosciences (RCUS) stake by 15% in Q2 2026, selling an estimated $618 and leaving 138 shares worth $4.26K. The position accounts for ﹤0.01% of the portfolio, ranked #4882.

Farther Finance Advisors first reported a position in RCUS in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.29K in Q4 2025. 23 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

Farther Finance Advisors held 138 shares of Arcus Biosciences worth $4.26K as of Q2 2026.
Farther Finance Advisors sold 25 Arcus Biosciences shares in Q2 2026, an estimated $618.
Arcus Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4882 holding.
Farther Finance Advisors first reported a position in Arcus Biosciences in Q4 2023 and has held it in 7 quarters since.
Farther Finance Advisors's Arcus Biosciences position peaked at $4.29K in Q4 2025.
23 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.